Altogen Biosystems Launches Custom Biotechnology Research Services: Generation of Stable Cell Lines and RNAi Cell Transfection Services
Altogen Biosystems announced launch of new contract research services. Altogen Custom Services focus on providing specialized biotechnology and pharmaceutical services, including RNA Interference (RNAi) services, generation of stably-expressing cell lines, assay development, screening and transfection services. In particular, the company will draw upon their unique experience with over hundred cancer cell lines and expertise in polymer and nanoparticle-based gene delivery technologies.
Posted: Mar 12th, 2008Read more